Metraipolis › archive › dc_f5545d327995

Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin — Europe PMC PMID:42855470

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42855470
DOI
10.1038/s41375-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-10-31T10:35:46.115Z
SHA-256 of the archived text
b4bc50113429e7409f9d6a83450763836c992eb91113ba018d11e0cc34d383fb
Stable URL of this page
https://metraipolis.com/documento/dc_f5545d327995

How to cite

Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin — Europe PMC PMID:42855470 — Europe PMC (en), https://europepmc.org/article/MED/42855470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f5545d327995 (Metraipolis archive dc_f5545d327995, sha256 b4bc50113429e7409f9d6a83450763836c992eb91113ba018d11e0cc34d383fb)
BibTeX
@misc{dcf5545d327995,
  title = {Predicting the clinical course of advanced systemic mastocytosis on treatment with avapritinib or midostaurin — Europe PMC PMID:42855470},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42855470},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f5545d327995; sha256 b4bc50113429e7409f9d6a83450763836c992eb91113ba018d11e0cc34d383fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42855470. Agents can read the archived copy with the MCP tool read_document.